Irinotecan hydrochloride and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Irinotecan hydrochloride (irinotecan hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fluorouracil, and have Colon cancer.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Irinotecan hydrochloride. It is created by eHealthMe based on reports of 7,131 people who have side effects when taking Irinotecan hydrochloride from the FDA, and is updated regularly.

What is Irinotecan hydrochloride?

Irinotecan hydrochloride has active ingredients of irinotecan hydrochloride. It is often used in cancer. eHealthMe is studying from 7,166 Irinotecan hydrochloride users. Check the latest studies of Irinotecan hydrochloride.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 14, 2026

7,131 people reported to have side effects when taking Irinotecan hydrochloride.
Among them, 32 people (0.45%) have Swallowing difficulty.

Could Irinotecan hydrochloride cause Swallowing difficulty?

Among these 32 people:

How long have people been on Irinotecan hydrochloride when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Irinotecan hydrochloride? *

female: 55.17 %
male: 44.83 %

What is the age of people who have Swallowing difficulty when taking Irinotecan hydrochloride? *

What are other drugs people take besides Irinotecan hydrochloride? *

What are other side effects people have besides Swallowing difficulty? *

Nausea (feeling of having an urge to vomit): 12 people, 37.50%
Nausea And Vomiting: 10 people, 31.25%
Diarrhea: 9 people, 28.12%
Fever: 8 people, 25.00%
Weakness: 6 people, 18.75%
Abdominal Pain: 5 people, 15.62%
Dehydration (dryness resulting from the removal of water): 5 people, 15.62%
Neuropathy Peripheral (surface nerve damage): 4 people, 12.50%
Hypotension (abnormally low blood pressure): 4 people, 12.50%
General Physical Health Deterioration (weak health status): 4 people, 12.50%

What are the existing conditions these people have? *

Colon Cancer: 9 people, 28.12%
Diabetes: 5 people, 15.62%
High Blood Pressure: 5 people, 15.62%
Nausea (feeling of having an urge to vomit): 5 people, 15.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.50%
Depression: 2 people, 6.25%
Constipation: 2 people, 6.25%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 6.25%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 6.25%
Vitamin B Complex Deficiency: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Irinotecan hydrochloride and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Irinotecan hydrochloride:

Irinotecan hydrochloride (7,166 reports)

Browse all side effects of Irinotecan hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irinotecan hydrochloride (the active ingredients of Irinotecan hydrochloride) and Irinotecan hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.